A Randomized, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study of DSP-1747 in Patients with Nonalcoholic Steatohepatitis

A Randomized, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study of DSP-1747 in Patients with Nonalcoholic Steatohepatitis(Phase 2 Study)

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221948

Enrollment

200

Registered

2012-10-25

Start date

2012-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic Steatohepatitis

Interventions

investigational material(s) Generic name etc : DSP-1747 INN of investigational material : Obeticholic acid Therapeutic category code : 391 Agents for liver disease Dosage and Administration for Inves

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with Nonalcoholic Steatohepatitis based on the liver biopsy -Outpatients etc.

Exclusion criteria

Exclusion criteria: - Patients with significant alcohol consumption - Patients with complication by other chronic liver disease etc.

Design outcomes

Primary

Measure	Time frame
Histological improvement Last observation	—

Secondary

Measure	Time frame
Change in indicators of hepatic function Change in disease markers Last observation	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026